Pritikin ICR LLC, Pritikin, Pritikin ICR

Source filing: WI · filed 2026-04-22

Item 5 — Initial franchise fee

Not disclosed

Item 6 — Recurring fees (royalty & advertising)

Not disclosed in extracted fee schedule — see FDD Item 6.

Item 7 — Estimated initial investment (total)

$5,750 [p.17 · WI · 2026-04-22] $52,500 [p.17 · WI · 2026-04-22]

Base single-franchise offering as stated in the FDD's total row. Multi-unit or area-development formats are not broken out here.

Item 20 — Outlets

Franchised outlets at start of year145 [p.46 · WI · 2026-04-22]
Franchised outlets at end of year182 [p.46 · WI · 2026-04-22]
Net change in franchised outlets37 [p.46 · WI · 2026-04-22]
Transfers0 [p.47 · WI · 2026-04-22]
Terminations1 [p.49 · WI · 2026-04-22]
Non-renewals0 [p.49 · WI · 2026-04-22]
Ceased operations (other)0 [p.49 · WI · 2026-04-22]
Company-owned outlets at end of yearNot disclosed

Item 19 — Financial performance representation

The filing's Item 19 contains no cohort eligible for headline presentation under this site's rules (franchised population, gross revenue/sales, annual, not a ranked subset).

All disclosed cohorts (1)

CohortOutletsAverageMedianHighLow
Licensee reported results for calendar year 2025 - 138 licensees with full twelve-month operation of Pritikin ICR Program, average number of Completed ICR Sessions for Medicare patients enrolled with 72-session prescription
calendar year 2025
138 [p.43 · WI · 2026-04-22] $46.90 [p.44 · WI · 2026-04-22] $47.60 [p.44 · WI · 2026-04-22] $72 [p.44 · WI · 2026-04-22] $14.70 [p.44 · WI · 2026-04-22]
“Some licensees have sold this much. Your individual results may differ. There is no assurance that you'll sell as much.” [p.44 · WI · 2026-04-22]

Extraction notes